Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Magnesium Sulphate in Craniotomy for Brain Tumors
NCT05743725Unknown
- Sponsor
- Assiut University
- Start
- Mar 2023
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine in brain tumor (2 arms), sponsored by Assiut University. Primary endpoint: Change in brain relaxation score. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
brain tumor
Beyond the preview
Go deeper on NCT05743725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05743725.